Exact Mass: 283.0606
Exact Mass Matches: 283.0606
Found 106 metabolites which its exact mass value is equals to given mass value 283.0606,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Penconazole
CONFIDENCE standard compound; INTERNAL_ID 411; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9666; ORIGINAL_PRECURSOR_SCAN_NO 9664 CONFIDENCE standard compound; INTERNAL_ID 411; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9722; ORIGINAL_PRECURSOR_SCAN_NO 9721 CONFIDENCE standard compound; INTERNAL_ID 411; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9751; ORIGINAL_PRECURSOR_SCAN_NO 9750 CONFIDENCE standard compound; INTERNAL_ID 411; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9670; ORIGINAL_PRECURSOR_SCAN_NO 9668 CONFIDENCE standard compound; INTERNAL_ID 411; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9676; ORIGINAL_PRECURSOR_SCAN_NO 9675 CONFIDENCE standard compound; INTERNAL_ID 411; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9793; ORIGINAL_PRECURSOR_SCAN_NO 9792 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3107 D016573 - Agrochemicals D010575 - Pesticides
2-Amino-4-(4-methoxyphenyl)-1-methyl-1H-imidazole-5-sulfonic acid
Penconazole
D016573 - Agrochemicals D010575 - Pesticides
5-Chloro-N-(1H-indol-5-yl)pyrazolo[1,5-a]pyrimidin-7-amine
8-METHYL-2-(5-METHYLTHIEN-2-YL)QUINOLINE-4-CARBOXYLIC ACID
3-[1-(3-chlorophenoxy)ethyl]-4-ethyl-1H-1,2,4-triazole-5-thione
2-Methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxylic acid ethyl ester 1,1-dioxide
(r)-3-amino-4-(3-trifluoromethylphenyl)butanoic acid hydrochloride
1-(4-CHLOROPHENYL)-1-(4-METHOXYPHENYL)METHYLAMINE HYDROCHLORIDE
(S)-3-AMINO-4-(3-(TRIFLUOROMETHYL)PHENYL)BUTANOIC ACID HYDROCHLORIDE
2-(4-NITRO-PHENYL)-3H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID
2-(2-NITRO-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID
2-(4-nitrophenyl)-1H-benzimidazole-4-carboxylic acid
3-[(4-chloro-3-methylphenoxy)methyl]-4-ethyl-1H-1,2,4-triazole-5-thione
2-(1,3-benzodioxol-5-yl)-6-nitroimidazo[1,2-a]pyridine
5-TERT-BUTYL-2-(3,4-DICHLORO-PHENYL)-2H-PYRAZOL-3-YLAMINE
CIS-1-OXO-SPIRO[CYCLOHEXANE-1,3(1H)-FURO[3,4-C]PYRIDINE]-4-CARBOXYLICACIDHYDROCHLORIDE
2-[(E)-2-(4-Hydrazinophenyl)vinyl]pyridine dihydrochloride
6-methyl-2-(5-methylthiophen-2-yl)quinoline-4-carboxylic acid
Dexpramipexole (dihydrochloride)
Dexpramipexole dihydrochloride ((R)-Pramipexole dihydrochloride) is a neuroprotective agent and weak non-ergoline dopamine agonist.
(R)-3-AMINO-4-(4-(TRIFLUOROMETHYL)PHENYL)BUTANOIC ACID HYDROCHLORIDE
(s)-3-amino-4-(2-trifluoromethylphenyl)butanoic acid hydrochloride
5-TERT-BUTYL-2-(2,6-DICHLORO-PHENYL)-2H-PYRAZOL-3-YLAMINE
5-TERT-BUTYL-2-(2,5-DICHLORO-PHENYL)-2H-PYRAZOL-3-YLAMINE
Pramipexole dihydrochloride
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists D020011 - Protective Agents > D000975 - Antioxidants Pramipexole dihydrochloride is a selective and blood-brain barrier (BBB) penetrant dopamine D2-type receptor agonist, with Kis of 2.2 nM, 3.9 nM, 0.5 nM and 1.3 nM for D2-type receptor, D2, D3 and D4 receptors, respectively. Pramipexole dihydrochloride can be used for the research of Parkinson's disease (PD) and restless legs syndrome (RLS)[1][2][3].
(s)-3-amino-4-(4-trifluoromethylphenyl)butanoic acid hydrochloride
Ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
(R)-Methyl 3-aMino-4-(2,4,5-trifluorophenyl)butanoate hydrochloride
(5,7-dioxo-5,7-dihydro-6H-pyrrolo[3,4-b]pyrazin-6-yl)(phenyl)acetic acid
2-(4-Trifluoromethylphenoxy)pyridine-5-boronic acid
ETHYL 1-(5-CHLORO-3-FLUOROPYRIDIN-2-YL)-5-METHYL-1H-PYRAZOLE-4-CARBOXYLATE
1-(3-BROMO-5-METHYLPYRIDIN-2-YL)-4-ETHYLPIPERAZINE
6-Benzyl-4-chloro-4,5,6,7-tetrahydro-3H-pyrrolo[3,4-d]pyrimidine hydrochloride
(r)-3-amino-4-(2-trifluoromethylphenyl)butanoic acid hydrochloride
N-(N-P-Nitro-Benzyloxycarbonyl)-Formimidoyl-2-Aminoethylthiol
3-(4-Chlorophenyl)quinoxaline-5-carboxamide
D000970 - Antineoplastic Agents > D000067856 - Poly(ADP-ribose) Polymerase Inhibitors D004791 - Enzyme Inhibitors
4-[4-(Trifluoromethyl)phenyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
2-[(4-Chlorophenyl)hydrazono]-3-oxo-3-phenylpropanenitrile
biochanin A(1-)
Conjugate base of biochanin A arising from selective deprotonation of the 7-hydroxy group; major species at pH 7.3.
5-hydroxy-2-(4-methoxyphenyl)-4-oxo-4H-chromen-7-olate
Conjugate base of 5,7-dihydroxy-4-methoxyflavone.
Calycosin(1-)
A flavonoid oxoanion obtained by deprotonation of the hydroxy group at position 7 of calycosin. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
Wogonin(1-)
The flavonoid oxoanion formed by deprotonation of the 7-hydroxy function of wogonin. Major structure at pH 7.3.
2-[1-(2-Hydroxyanilino)ethylidene]-1-benzothiophen-3-one
Prunetin-5-olate
A flavonoid oxoanion obtained by deprotonation of the 5-hydroxy group of prunetin. It is the major microspecies at pH 7.3
(Z)-N-(3-Chlorophenyl)-2-cyano-3-pyridin-3-ylprop-2-enamide
(2S,3S,4R,5R)-3,4,5-trihydroxy-6-(pyridine-4-carbonyl)oxane-2-carboxylic acid
ALDH1A3-IN-1
ALDH1A3-IN-1 (Compound 14) is a potent ALDH1A3 inhibitor, with an IC50 of 0.63 μM and a Ki of 0.46 μM. ALDH1A3-IN-1 can be studied in prostate cancer[1].
Varenicline (dihydrochloride)
Varenicline (CP 526555-18) is an orally active partial agonist of α4β2 nicotinic acetylcholine receptor (α4β2 nAChR, IC50 = 250 nM), which is the principal mediator of nicotine dependence. Varenicline is also a partial agonist of α6β2 nAChR and a full agonist of α6β2 nAChR. Varenicline blocks the direct agonist effects of nicotine on nAChR while stimulates nAChR in a more moderate way, being widely used as an aid of smoking cessation[1][2][3][4][5].
